Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Curr Opin Neurol. 2010 Feb;23(1):73–78. doi: 10.1097/wco.0b013e3283352dbc

Figure 4.

Figure 4

This figure is based on the following assumptions: 1) annualized average stroke recurrence risk is 2%; 2) degree of risk heterogeneity is moderate (extreme quintile risk ratio is 20); 3) 60% of recurrent strokes are caused by paradoxical embolism; 4) PFO devices are 100% effective in preventing recurrent paradoxical embolism; and 5) PFO devices are associated with a small degree of treatment-related stroke risk (2 in 1000 per year).